Glutamine and NAA dissociate in ALS across somatotopically defined motor regions using 7T MRSI
Abstract
Amyotrophic lateral sclerosis (ALS) is increasingly understood as a progressive neurodegenerative disorder with distributed cortical and subcortical involvement, but in vivo metabolic mapping has been limited by the spatial coverage of single-voxel proton magnetic resonance spectroscopy (MRS). We acquired high-resolution whole-brain 7T 3D-CRT-FID-MRSI alongside motor-cortex single-voxel sLASER in five rapidly progressing people living with ALS (plALS) and seven non-neurodegenerative controls (NCs), with up to three sessions per participant. Regional metabolite ratios (N-Acetylaspartate [tNAA], glutamate [Glu], glutamine [Gln] to creatine [tCr], and Glu+Gln [Glx] to tNAA) were modelled with Bayesian hierarchical mixed-effects models, and the primary motor cortex was subdivided along its dorsoventral somatotopic axis (bulbar/face, hand/upper-limb, foot/lower-limb). At baseline, plALS showed a motor-cortex-selective tNAA/tCr deficit (motor composite −8.7%, 95% credible Interval [CrI] −16.1 to −1.1, posterior probability=0.99) accompanied by cortically diffuse glutamatergic elevation (Gln/tCr +25.6%, posterior probability=0.96; Glx/tNAA +10.4%, posterior probability=0.95). Reliable separation of the J-coupled glutamine and glutamate resonances at 7T revealed Gln/tCr as a more sensitive marker of glutamatergic dysregulation than Glu/tCr alone in this cohort. Within the somatotopic subdivision, all five plALS showed their peak Gln/tCr increase in the bulbar/face zone irrespective…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.